Page 19 - Diagnostic Testing Segmentation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostic testing segmentation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostic Testing Segmentation Today - Breaking & Trending Today

Veracyte to acquire C2i Genomics for up to $95M

Veracyte Inc. revealed plans to buy C2i Genomics Inc. at the J.P. Morgan Health Care Conference in San Francisco on Jan. 8, a move that will significantly expand its portfolio of cancer diagnostic and monitoring assays. The terms include $70 million in Veracyte shares to be paid at closing plus an addition $25 million payable in cash or Veracyte shares over the next two years if C2i achieves certain performance milestones. ....

Veracyte Inc , Jp Morgan Health Care Conference , Genomics Inc , Health Care Conference , San Francisco , Veracyte Inc , C2i Genomics Inc , Prostate Cancer , Bladder Cancer , Lung Cancer , Kidney Cancer , Thyroid Cancer , Afirma Gsc ,